Proteomics Program Officer
The Clinical Proteomics Centers for Infectious Diseases and Biodefense apply state-of-the-art proteomics technologies for the discovery, qualification, and verification of protein biomarkers in well-defined clinical samples collected for infectious diseases caused by NIAID Category A-C biodefense pathogens and emerging and re-emerging infectious diseases.
Proteomic analyses on well-defined case versus control clinical samples will be performed by University of Texas Medical Branch at Galveston.
Center-generated data will be made available through publicly accessible web and database sites, including the NIAID Bioinformatic Resource Centers.
Last Updated January 23, 2014